Finkelstein J A, Metlay J P, Davis R L, Rifas-Shiman S L, Dowell S F, Platt R
Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, Mass 02215, USA.
Arch Pediatr Adolesc Med. 2000 Apr;154(4):395-400. doi: 10.1001/archpedi.154.4.395.
Antimicrobial overprescribing contributes to bacterial resistance, but data on use in infants and young children are limited.
To assess antimicrobial use in a defined population of infants and young children and to determine diagnosis-specific prescribing rates for common infections.
Retrospective cohort study of children served by 44 practices affiliated with 2 managed care organizations.
Children aged 3 months to 72 months enrolled in either health plan between September 1, 1994, and August 31, 1996.
Rates of antimicrobial use were calculated as the number of pharmacy dispensings divided by the number of person-years of observation contributed to the cohort in 2 age groups (3 to <36 months and 36 to <72 months). Other outcomes included the distribution of diagnoses associated with antimicrobial dispensing and population-based rates of diagnosis of common acute respiratory tract illnesses.
A total of 46477 children contributed 59710 person-years of observation across the 2 health plans. Rates of antimicrobial dispensing for children aged 3 to 36 months were 3.2 and 2.1 dispensings per person-year in the 2 populations. A substantial fraction of younger children (35% in population A and 23% in population B) received 4 or more antimicrobial prescriptions in a single year. For children aged 36 to 72 months, the dispensing rates for the 2 populations were 2.0 and 1.5 antimicrobials per person-year. We found significant differences in rates between the populations studied and a decrease in use at all sites from 1995 to 1996. The diagnosis of otitis media accounted for 56% of antimicrobial drugs dispensed to children aged 3 to 36 months and 40% of those dispensed to children aged 36 to 72 months. Antimicrobial prescribing for colds and upper respiratory tract infections, bronchitis, and sinusitis was less frequent than previously reported but accounted for 10% to 14% of antimicrobial drugs dispensed.
In these populations, otitis media accounted for the largest number of antimicrobial agents dispensed to children younger than 6 years. Clearly inappropriate indications such as cold, upper respiratory tract infection, and bronchitis accounted for smaller fractions of antimicrobial use but may be most amenable to change. However, interventions that encourage use of strict criteria for diagnosis and treatment of otitis media will likely have the greatest impact on overall antimicrobial exposure. Monitoring defined populations longitudinally will allow assessment of the effectiveness of such national and local initiatives.
抗菌药物的过度开具会导致细菌耐药性,但关于婴幼儿使用抗菌药物的数据有限。
评估特定人群中婴幼儿的抗菌药物使用情况,并确定常见感染的诊断特异性开具率。
对隶属于2个管理式医疗组织的44家医疗机构所服务的儿童进行回顾性队列研究。
1994年9月1日至1996年8月31日期间参加任一健康计划的3个月至72个月大的儿童。
抗菌药物使用发生率的计算方法为药房配药次数除以两个年龄组(3至<36个月和36至<72个月)对队列贡献的人年观察数。其他结果包括与抗菌药物配药相关的诊断分布以及常见急性呼吸道疾病的人群诊断率。
在这两个健康计划中,共有46477名儿童贡献了59710人年的观察数据。3至36个月大儿童的抗菌药物配药率在两个人群中分别为每人年3.2次和2.1次。很大一部分年幼儿童(A人群中为35%,B人群中为23%)在一年内接受了4次或更多的抗菌药物处方。对于36至72个月大的儿童,两个人群的配药率分别为每人年2.0次和1.5次。我们发现所研究人群之间的发生率存在显著差异,并且从1995年到1996年所有地点的使用量均有所下降。中耳炎的诊断占3至36个月大儿童所配抗菌药物的56%,占36至72个月大儿童所配抗菌药物的40%。感冒和上呼吸道感染、支气管炎以及鼻窦炎的抗菌药物开具频率低于先前报告,但占所配抗菌药物的10%至14%。
在这些人群中,中耳炎是6岁以下儿童所配抗菌药物数量最多的疾病。感冒、上呼吸道感染和支气管炎等明显不恰当的适应症占抗菌药物使用的比例较小,但可能最容易改变。然而,鼓励使用严格的中耳炎诊断和治疗标准的干预措施可能对总体抗菌药物暴露产生最大影响。对特定人群进行纵向监测将有助于评估此类国家和地方举措的有效性。